The South Korean pharma company’s US subsidiary is purchasing Eli Lilly’s Branchburg, NJ site to safeguard against potential ...

This episode of Pharma Pulse covers ACIP’s move toward shared decision-making for COVID-19 vaccines, Pfizer’s acquisition of ...

Ullrich Mayeski, community engagement director of health with GS1 US, describes of the organization’s EPCIS standard for meeting DSCSA requirements while underscoring that true supply chain success ...

The platform enables clinicians to tailor GLP-1 titration at scale, aiming to reduce discontinuation rates and improve ...

This episode of Pharma Pulse covers the CDC’s decision to postpone changes to Hepatitis B vaccine guidance, new research ...

Takeda will be shipping treatments between Europe and the US using VELA’s sailing cargo trimaran, potentially reducing ...

In the third part of his Pharma Commerce video interview, Derrick Gastineau, head of marketing with Currax Pharmaceuticals, ...

This episode of Pharma Pulse covers new data showing 1 in 6 US parents are delaying or skipping childhood vaccinations, ...

The new Goochland County facility will serve as Lilly’s first fully integrated API and drug product site, focusing on ...

This episode of Pharma Pulse covers GSK’s $30 billion plan to expand US biopharma production, new evidence that weekly GLP-1 therapies significantly reduce cardiovascular risks, and Roche’s ...

The draft assessment finds that the popular weight loss drugs are costly but worth the price tag, while also urging for ...

This episode of Pharma Pulse covers reports of a White House executive order to restrict treatments discovered in China, new ...